この専門家をプロジェクトに採用したいですか？ 見積もりを依頼 無料で。
プロフィール詳細
Dr. Donald A.に依頼
United States
Biochemist & Molecular Biologist | Expert in IP and Product Development | Scientist with 20+ years in research
プロフィール概要
専門分野
サービス
Writing
Technical Writing
Research
Market Research,
Gap Analysis,
Scientific and Technical Research
Consulting
Business Strategy Consulting,
Go-to-Market Strategy Consulting,
Healthcare Consulting,
Scientific and Technical Consulting,
Manufacturing Consulting
Data & AI
Image Processing,
Image Analysis
Product Development
Recipe Development,
Stability/Shelf Life Testing,
Product Validation,
Manufacturing,
Concept Development,
Prototyping,
Reverse Engineering
職務経験
President
Cytolytics
- 現在 
505Bio
- 現在
Chief Scientific Officer
505Bio
5月 2025 - 現在
President
Anderson BioInnovations, LLC
1月 2025 - 現在
Scientific Advisor
Biogut Technologies, Inc.
12月 2023 - 現在
Scientific Advisor
Black Arrow Biotech
12月 2023 - 現在
Scientific Advisor
Summa Biosolutions, Inc.
12月 2023 - 現在
CEO
Biogut Technologies
12月 2023 - 5月 2025
Senior Innovation Manager
Baylor University
5月 2023 - 6月 2024
Senior Innovation Manager
Baylor University
10月 2021 - 6月 2024
Director, BioMedTech
Baylor University
9月 2021 - 5月 2023
Consultant
etiraRX, Inc.
7月 2020 - 9月 2021
Senior Scientist / Group Manager
Merck
8月 2019 - 8月 2020
Senior Scientist / Group Manager
Peloton Therapeutics
7月 2018 - 8月 2020
Senior Scientist
Merck & Co., Inc., Rahway, NJ, USA
5月 2019 - 6月 2020
Senior Scientist
Peloton Therapeutics
6月 2018 - 2019
Senior Scientist
University Texas Southwestern Medical
11月 2013 - 7月 2018
学歴
MBA
University of North Texas
- 現在
MBA
University of North Texas
2月 2019 - 8月 2020
PhD, Biochemistry
Cornell University
8月 2007 - 8月 2011
PhD (Biochemistry)
Cornell University
7月 2007 - 6月 2011
BS
Cornell University
8月 2004 - 5月 2006
認定資格
出版物
JOURNAL ARTICLE
Dovrolis N, Spathakis M, Collins AR, Pandey VK, Uddin MI, Anderson DD, Kaminska T, Paspaliaris V, Kolios G(2024). Pan-Cancer Insights: A Study of Microbial Metabolite Receptors in Malignancy Dynamics . Cancers.
Das A, Brown MS, Anderson DD, Goldstein JL, Radhakrishnan A(2014). Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis . eLife.
Das A, Goldstein JL, Anderson DD, Brown MS, Radhakrishnan A(2013). Use of mutant 125I-perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells . Proceedings of the National Academy of Sciences of the United States of America.
Anderson DD, Woeller CF, Chiang EP, Shane B, Stover PJ(2012). Serine hydroxymethyltransferase anchors de novo thymidylate synthesis pathway to nuclear lamina for DNA synthesis . The Journal of biological chemistry.
Anderson DD, Eom JY, Stover PJ(2011). Competition between sumoylation and ubiquitination of serine hydroxymethyltransferase 1 determines its nuclear localization and its accumulation in the nucleus . The Journal of biological chemistry.
MacFarlane AJ, Anderson DD, Flodby P, Perry CA, Allen RH, Stabler SP, Stover PJ(2011). Nuclear localization of de novo thymidylate biosynthesis pathway is required to prevent uracil accumulation in DNA . The Journal of biological chemistry.
Anderson DD, Quintero CM, Stover PJ(2011). Identification of a de novo thymidylate biosynthesis pathway in mammalian mitochondria . Proceedings of the National Academy of Sciences of the United States of America.
Field MS, Anderson DD, Stover PJ(2011). Mthfs is an Essential Gene in Mice and a Component of the Purinosome . Frontiers in genetics.
Anderson DD, Stover PJ(2009). SHMT1 and SHMT2 are functionally redundant in nuclear de novo thymidylate biosynthesis . PloS one.
Woeller CF, Anderson DD, Szebenyi DM, Stover PJ(2007). Evidence for small ubiquitin-like modifier-dependent nuclear import of the thymidylate biosynthesis pathway . The Journal of biological chemistry.
Anderson DD, Woeller CF, Stover PJ(2007). Small ubiquitin-like modifier-1 (SUMO-1) modification of thymidylate synthase and dihydrofolate reductase . Clinical chemistry and laboratory medicine.
評価とコメント
受注プロジェクト総数:
コメント: